ASP Isotopes (NASDAQ:ASPI) Sees Strong Trading Volume - Should You Buy?

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) saw strong trading volume on Wednesday . 2,041,157 shares traded hands during mid-day trading, a decline of 1% from the previous session's volume of 2,058,871 shares.The stock last traded at $7.44 and had previously closed at $7.00.

ASP Isotopes Price Performance

The stock has a market capitalization of $605.38 million, a price-to-earnings ratio of -13.23 and a beta of 3.40. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. The stock has a 50-day simple moving average of $5.34 and a 200 day simple moving average of $5.44.

Insider Transactions at ASP Isotopes

In other news, COO Robert Ainscow sold 66,668 shares of the company's stock in a transaction on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $374,674.16. Following the transaction, the chief operating officer now directly owns 1,419,992 shares of the company's stock, valued at approximately $7,980,355.04. This represents a 4.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Paul Elliot Mann sold 316,666 shares of the stock in a transaction on Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $1,779,662.92. Following the sale, the chief executive officer now owns 7,315,454 shares of the company's stock, valued at approximately $41,112,851.48. This represents a 4.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 766,667 shares of company stock valued at $4,358,502 over the last three months. 21.40% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On ASP Isotopes

Hedge funds have recently added to or reduced their stakes in the company. Barclays PLC increased its stake in shares of ASP Isotopes by 438.5% during the 3rd quarter. Barclays PLC now owns 72,330 shares of the company's stock worth $201,000 after purchasing an additional 58,897 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in ASP Isotopes by 31.4% in the third quarter. JPMorgan Chase & Co. now owns 22,196 shares of the company's stock worth $62,000 after purchasing an additional 5,307 shares in the last quarter. SG Americas Securities LLC bought a new stake in ASP Isotopes in the fourth quarter worth $100,000. Hanson & Doremus Investment Management acquired a new position in ASP Isotopes during the fourth quarter worth $27,000. Finally, Almanack Investment Partners LLC. bought a new position in ASP Isotopes during the fourth quarter valued at about $68,000. Institutional investors and hedge funds own 16.80% of the company's stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.